HEADER SIGNALING PROTEIN 16-SEP-13 4MQT TITLE STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TITLE 2 TO THE AGONIST IPEROXO AND ALLOSTERIC MODULATOR LY2119620 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUSCARINIC ACETYLCHOLINE RECEPTOR M2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-232,373-466; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NANOBODY 9-8; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CHRM2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PVL1392; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 12 ORGANISM_TAXID: 9844; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 17 EXPRESSION_SYSTEM_PLASMID: PMAL3CBN KEYWDS G PROTEIN-COUPLED RECEPTOR, MUSCARINIC ACETYLCHOLINE RECEPTOR, KEYWDS 2 ALLOSTERIC MODULATION, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.C.KRUSE,A.M.RING,A.MANGLIK,J.HU,K.HU,K.EITEL,H.HUEBNER,E.PARDON, AUTHOR 2 C.VALANT,P.M.SEXTON,A.CHRISTOPOULOS,C.C.FELDER,P.GMEINER,J.STEYAERT, AUTHOR 3 W.I.WEIS,K.C.GARCIA,J.WESS,B.K.KOBILKA REVDAT 7 06-NOV-24 4MQT 1 REMARK REVDAT 6 20-SEP-23 4MQT 1 REMARK SEQADV REVDAT 5 01-MAY-19 4MQT 1 HETSYN REVDAT 4 05-JUL-17 4MQT 1 SOURCE REVDAT 3 18-DEC-13 4MQT 1 JRNL REVDAT 2 04-DEC-13 4MQT 1 JRNL REVDAT 1 27-NOV-13 4MQT 0 JRNL AUTH A.C.KRUSE,A.M.RING,A.MANGLIK,J.HU,K.HU,K.EITEL,H.HUBNER, JRNL AUTH 2 E.PARDON,C.VALANT,P.M.SEXTON,A.CHRISTOPOULOS,C.C.FELDER, JRNL AUTH 3 P.GMEINER,J.STEYAERT,W.I.WEIS,K.C.GARCIA,J.WESS,B.K.KOBILKA JRNL TITL ACTIVATION AND ALLOSTERIC MODULATION OF A MUSCARINIC JRNL TITL 2 ACETYLCHOLINE RECEPTOR. JRNL REF NATURE V. 504 101 2013 JRNL REFN ISSN 0028-0836 JRNL PMID 24256733 JRNL DOI 10.1038/NATURE12735 REMARK 2 REMARK 2 RESOLUTION. 3.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_1241) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 3 NUMBER OF REFLECTIONS : 7867 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.255 REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.301 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.910 REMARK 3 FREE R VALUE TEST SET COUNT : 780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.2016 - 6.7114 0.95 1291 144 0.2316 0.2484 REMARK 3 2 6.7114 - 5.3325 0.96 1229 134 0.2853 0.3905 REMARK 3 3 5.3325 - 4.6600 0.95 1202 133 0.2103 0.2513 REMARK 3 4 4.6600 - 4.2347 0.94 1158 135 0.2258 0.2975 REMARK 3 5 4.2347 - 3.9315 0.93 1164 124 0.2881 0.3816 REMARK 3 6 3.9315 - 3.7000 0.84 1043 110 0.3140 0.3637 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.590 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3142 REMARK 3 ANGLE : 0.811 4309 REMARK 3 CHIRALITY : 0.060 508 REMARK 3 PLANARITY : 0.003 525 REMARK 3 DIHEDRAL : 14.109 1047 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MQT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000082250. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7871 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.700 REMARK 200 RESOLUTION RANGE LOW (A) : 36.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.19500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.60500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4MQS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RECONSTITUTED IN 10:1 REMARK 280 MONOOLEIN:CHOLESTEROL MIX. PRECIPITANT SOLUTION: 0.5 MM REMARK 280 LY2119620, 10 - 20% PEG300, 100 MM HEPES PH 7.2 - 7.9, 1.2% 1,2, REMARK 280 3-HEPTANETRIOL, AND 20 - 80 MM EDTA PH 8.0, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.51600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.91100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.69950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.91100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.51600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.69950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -16 REMARK 465 TYR A -15 REMARK 465 LYS A -14 REMARK 465 ASP A -13 REMARK 465 ASP A -12 REMARK 465 ASP A -11 REMARK 465 GLU A -10 REMARK 465 ASN A -9 REMARK 465 LEU A -8 REMARK 465 TYR A -7 REMARK 465 PHE A -6 REMARK 465 GLN A -5 REMARK 465 GLY A -4 REMARK 465 LEU A -3 REMARK 465 GLU A -2 REMARK 465 MET A -1 REMARK 465 ASP A 0 REMARK 465 ASP A 1 REMARK 465 SER A 2 REMARK 465 THR A 3 REMARK 465 ASP A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 ASP A 7 REMARK 465 ASN A 8 REMARK 465 SER A 9 REMARK 465 LEU A 10 REMARK 465 ALA A 11 REMARK 465 LEU A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 PRO A 15 REMARK 465 TYR A 16 REMARK 465 LEU A 17 REMARK 465 GLU A 18 REMARK 465 SER A 215 REMARK 465 ARG A 216 REMARK 465 ILE A 217 REMARK 465 LYS A 218 REMARK 465 LYS A 219 REMARK 465 ASP A 220 REMARK 465 LYS A 221 REMARK 465 LYS A 222 REMARK 465 GLU A 223 REMARK 465 PRO A 224 REMARK 465 VAL A 225 REMARK 465 ALA A 226 REMARK 465 ASN A 227 REMARK 465 GLN A 228 REMARK 465 ASP A 229 REMARK 465 PRO A 230 REMARK 465 VAL A 231 REMARK 465 SER A 232 REMARK 465 THR A 373 REMARK 465 ARG A 374 REMARK 465 LYS A 375 REMARK 465 LYS A 376 REMARK 465 PRO A 377 REMARK 465 PRO A 378 REMARK 465 HIS A 458 REMARK 465 TYR A 459 REMARK 465 LYS A 460 REMARK 465 ASN A 461 REMARK 465 ILE A 462 REMARK 465 GLY A 463 REMARK 465 ALA A 464 REMARK 465 THR A 465 REMARK 465 ARG A 466 REMARK 465 HIS A 467 REMARK 465 HIS A 468 REMARK 465 HIS A 469 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 GLY B -3 REMARK 465 PRO B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 19 CG CD CE NZ REMARK 470 PHE A 21 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 52 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 134 CG CD CE NZ REMARK 470 LYS A 138 CG CD CE NZ REMARK 470 MET A 139 CG SD CE REMARK 470 ILE A 165 CG1 CG2 CD1 REMARK 470 ASP A 173 CG OD1 OD2 REMARK 470 GLU A 175 CG CD OE1 OE2 REMARK 470 PHE A 181 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 ARG A 381 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 382 CG CD OE1 OE2 REMARK 470 LYS A 383 CG CD CE NZ REMARK 470 LYS A 448 CG CD CE NZ REMARK 470 LYS A 449 CG CD CE NZ REMARK 470 MET A 456 CG SD CE REMARK 470 CYS A 457 SG REMARK 470 GLN B 1 CG CD OE1 NE2 REMARK 470 ASP B 28 CG OD1 OD2 REMARK 470 ASP B 58 CG OD1 OD2 REMARK 470 LYS B 68 CG CD CE NZ REMARK 470 ASP B 76 CG OD1 OD2 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 LEU B 104 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASP B 33 OG SER B 57 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 195 -60.84 -128.21 REMARK 500 PRO A 418 -162.33 -72.17 REMARK 500 MET A 456 21.54 -79.11 REMARK 500 PHE B 29 -57.22 68.81 REMARK 500 PRO B 44 106.58 -48.87 REMARK 500 ASP B 108 72.61 41.20 REMARK 500 SER B 120 -167.18 -78.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IXO A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CU A 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3UON RELATED DB: PDB REMARK 900 STRUCTURE OF THE M2 MUSCARINIC RECEPTOR IN AN INACTIVE CONFORMATION REMARK 900 RELATED ID: 4MQS RELATED DB: PDB REMARK 900 STRUCTURE OF ACTIVE M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO REMARK 900 THE AGONIST IPEROXO DBREF 4MQT A -1 232 UNP P08172 ACM2_HUMAN 1 232 DBREF 4MQT A 373 466 UNP P08172 ACM2_HUMAN 373 466 DBREF 4MQT B -3 121 PDB 4MQT 4MQT -3 121 SEQADV 4MQT ASP A -16 UNP P08172 EXPRESSION TAG SEQADV 4MQT TYR A -15 UNP P08172 EXPRESSION TAG SEQADV 4MQT LYS A -14 UNP P08172 EXPRESSION TAG SEQADV 4MQT ASP A -13 UNP P08172 EXPRESSION TAG SEQADV 4MQT ASP A -12 UNP P08172 EXPRESSION TAG SEQADV 4MQT ASP A -11 UNP P08172 EXPRESSION TAG SEQADV 4MQT GLU A -10 UNP P08172 EXPRESSION TAG SEQADV 4MQT ASN A -9 UNP P08172 EXPRESSION TAG SEQADV 4MQT LEU A -8 UNP P08172 EXPRESSION TAG SEQADV 4MQT TYR A -7 UNP P08172 EXPRESSION TAG SEQADV 4MQT PHE A -6 UNP P08172 EXPRESSION TAG SEQADV 4MQT GLN A -5 UNP P08172 EXPRESSION TAG SEQADV 4MQT GLY A -4 UNP P08172 EXPRESSION TAG SEQADV 4MQT LEU A -3 UNP P08172 EXPRESSION TAG SEQADV 4MQT GLU A -2 UNP P08172 EXPRESSION TAG SEQADV 4MQT ASP A 0 UNP P08172 ASN 2 ENGINEERED MUTATION SEQADV 4MQT ASP A 1 UNP P08172 ASN 3 ENGINEERED MUTATION SEQADV 4MQT ASP A 4 UNP P08172 ASN 6 ENGINEERED MUTATION SEQADV 4MQT ASP A 7 UNP P08172 ASN 9 ENGINEERED MUTATION SEQADV 4MQT LEU A 17 UNP P08172 INSERTION SEQADV 4MQT GLU A 18 UNP P08172 INSERTION SEQADV 4MQT THR A 373 UNP P08172 ALA 373 ENGINEERED MUTATION SEQADV 4MQT ARG A 374 UNP P08172 LYS 374 ENGINEERED MUTATION SEQADV 4MQT HIS A 467 UNP P08172 EXPRESSION TAG SEQADV 4MQT HIS A 468 UNP P08172 EXPRESSION TAG SEQADV 4MQT HIS A 469 UNP P08172 EXPRESSION TAG SEQADV 4MQT HIS A 470 UNP P08172 EXPRESSION TAG SEQADV 4MQT HIS A 471 UNP P08172 EXPRESSION TAG SEQADV 4MQT HIS A 472 UNP P08172 EXPRESSION TAG SEQADV 4MQT HIS A 473 UNP P08172 EXPRESSION TAG SEQADV 4MQT HIS A 474 UNP P08172 EXPRESSION TAG SEQRES 1 A 351 ASP TYR LYS ASP ASP ASP GLU ASN LEU TYR PHE GLN GLY SEQRES 2 A 351 LEU GLU MET ASP ASP SER THR ASP SER SER ASP ASN SER SEQRES 3 A 351 LEU ALA LEU THR SER PRO TYR LEU GLU LYS THR PHE GLU SEQRES 4 A 351 VAL VAL PHE ILE VAL LEU VAL ALA GLY SER LEU SER LEU SEQRES 5 A 351 VAL THR ILE ILE GLY ASN ILE LEU VAL MET VAL SER ILE SEQRES 6 A 351 LYS VAL ASN ARG HIS LEU GLN THR VAL ASN ASN TYR PHE SEQRES 7 A 351 LEU PHE SER LEU ALA CYS ALA ASP LEU ILE ILE GLY VAL SEQRES 8 A 351 PHE SER MET ASN LEU TYR THR LEU TYR THR VAL ILE GLY SEQRES 9 A 351 TYR TRP PRO LEU GLY PRO VAL VAL CYS ASP LEU TRP LEU SEQRES 10 A 351 ALA LEU ASP TYR VAL VAL SER ASN ALA SER VAL MET ASN SEQRES 11 A 351 LEU LEU ILE ILE SER PHE ASP ARG TYR PHE CYS VAL THR SEQRES 12 A 351 LYS PRO LEU THR TYR PRO VAL LYS ARG THR THR LYS MET SEQRES 13 A 351 ALA GLY MET MET ILE ALA ALA ALA TRP VAL LEU SER PHE SEQRES 14 A 351 ILE LEU TRP ALA PRO ALA ILE LEU PHE TRP GLN PHE ILE SEQRES 15 A 351 VAL GLY VAL ARG THR VAL GLU ASP GLY GLU CYS TYR ILE SEQRES 16 A 351 GLN PHE PHE SER ASN ALA ALA VAL THR PHE GLY THR ALA SEQRES 17 A 351 ILE ALA ALA PHE TYR LEU PRO VAL ILE ILE MET THR VAL SEQRES 18 A 351 LEU TYR TRP HIS ILE SER ARG ALA SER LYS SER ARG ILE SEQRES 19 A 351 LYS LYS ASP LYS LYS GLU PRO VAL ALA ASN GLN ASP PRO SEQRES 20 A 351 VAL SER THR ARG LYS LYS PRO PRO PRO SER ARG GLU LYS SEQRES 21 A 351 LYS VAL THR ARG THR ILE LEU ALA ILE LEU LEU ALA PHE SEQRES 22 A 351 ILE ILE THR TRP ALA PRO TYR ASN VAL MET VAL LEU ILE SEQRES 23 A 351 ASN THR PHE CYS ALA PRO CYS ILE PRO ASN THR VAL TRP SEQRES 24 A 351 THR ILE GLY TYR TRP LEU CYS TYR ILE ASN SER THR ILE SEQRES 25 A 351 ASN PRO ALA CYS TYR ALA LEU CYS ASN ALA THR PHE LYS SEQRES 26 A 351 LYS THR PHE LYS HIS LEU LEU MET CYS HIS TYR LYS ASN SEQRES 27 A 351 ILE GLY ALA THR ARG HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 1 B 125 GLY PRO GLY SER GLN VAL GLN LEU GLN GLU SER GLY GLY SEQRES 2 B 125 GLY LEU VAL GLN ALA GLY ASP SER LEU ARG LEU SER CYS SEQRES 3 B 125 ALA ALA SER GLY PHE ASP PHE ASP ASN PHE ASP ASP TYR SEQRES 4 B 125 ALA ILE GLY TRP PHE ARG GLN ALA PRO GLY GLN GLU ARG SEQRES 5 B 125 GLU GLY VAL SER CYS ILE ASP PRO SER ASP GLY SER THR SEQRES 6 B 125 ILE TYR ALA ASP SER ALA LYS GLY ARG PHE THR ILE SER SEQRES 7 B 125 SER ASP ASN ALA GLU ASN THR VAL TYR LEU GLN MET ASN SEQRES 8 B 125 SER LEU LYS PRO GLU ASP THR ALA VAL TYR VAL CYS SER SEQRES 9 B 125 ALA TRP THR LEU PHE HIS SER ASP GLU TYR TRP GLY GLN SEQRES 10 B 125 GLY THR GLN VAL THR VAL SER SER HET IXO A 501 14 HET 2CU A 502 29 HETNAM IXO 4-(4,5-DIHYDRO-1,2-OXAZOL-3-YLOXY)-N,N,N-TRIMETHYLBUT- HETNAM 2 IXO 2-YN-1-AMINIUM HETNAM 2CU 3-AMINO-5-CHLORO-N-CYCLOPROPYL-4-METHYL-6-[2-(4- HETNAM 2 2CU METHYLPIPERAZIN-1-YL)-2-OXOETHOXY]THIENO[2,3- HETNAM 3 2CU B]PYRIDINE-2-CARBOXAMIDE HETSYN IXO IPEROXO HETSYN 2CU LY2119620 POSITIVE ALLOSTERIC MODULATOR OF M2/M4 HETSYN 2 2CU RECEPTOR FORMUL 3 IXO C10 H17 N2 O2 1+ FORMUL 4 2CU C19 H24 CL N5 O3 S HELIX 1 1 GLU A 22 VAL A 50 1 29 HELIX 2 2 ASN A 58 ILE A 71 1 14 HELIX 3 3 MET A 77 ILE A 86 1 10 HELIX 4 4 PRO A 93 THR A 126 1 34 HELIX 5 5 TYR A 131 LYS A 134 1 4 HELIX 6 6 THR A 137 LEU A 160 1 24 HELIX 7 7 TRP A 162 VAL A 166 1 5 HELIX 8 8 ALA A 184 ALA A 191 1 8 HELIX 9 9 LEU A 197 SER A 213 1 17 HELIX 10 10 SER A 380 ASN A 410 1 31 HELIX 11 11 THR A 420 TYR A 430 1 11 HELIX 12 12 ASN A 432 ASN A 436 1 5 HELIX 13 13 ALA A 445 LEU A 455 1 11 HELIX 14 14 ASN B 31 ASP B 33 5 3 HELIX 15 15 LYS B 90 THR B 94 5 5 SHEET 1 A 4 LEU B 4 GLU B 6 0 SHEET 2 A 4 LEU B 18 ALA B 24 -1 O ALA B 23 N GLN B 5 SHEET 3 A 4 THR B 81 MET B 86 -1 O LEU B 84 N LEU B 20 SHEET 4 A 4 PHE B 71 ASP B 76 -1 N THR B 72 O GLN B 85 SHEET 1 B 6 LEU B 11 VAL B 12 0 SHEET 2 B 6 THR B 115 VAL B 119 1 O THR B 118 N VAL B 12 SHEET 3 B 6 ALA B 95 THR B 103 -1 N TYR B 97 O THR B 115 SHEET 4 B 6 TYR B 35 GLN B 42 -1 N GLY B 38 O SER B 100 SHEET 5 B 6 GLU B 49 ASP B 55 -1 O ILE B 54 N ILE B 37 SHEET 6 B 6 SER B 60 TYR B 63 -1 O ILE B 62 N CYS B 53 SHEET 1 C 4 LEU B 11 VAL B 12 0 SHEET 2 C 4 THR B 115 VAL B 119 1 O THR B 118 N VAL B 12 SHEET 3 C 4 ALA B 95 THR B 103 -1 N TYR B 97 O THR B 115 SHEET 4 C 4 SER B 107 TRP B 111 -1 O TYR B 110 N ALA B 101 SSBOND 1 CYS A 96 CYS A 176 1555 1555 2.03 SSBOND 2 CYS A 413 CYS A 416 1555 1555 2.03 SSBOND 3 CYS B 22 CYS B 99 1555 1555 2.03 SITE 1 AC1 13 ASP A 103 TYR A 104 SER A 107 ASN A 108 SITE 2 AC1 13 VAL A 111 TRP A 155 ALA A 194 TRP A 400 SITE 3 AC1 13 TYR A 403 ASN A 404 TYR A 426 CYS A 429 SITE 4 AC1 13 TYR A 430 SITE 1 AC2 10 TYR A 80 TYR A 83 TYR A 177 PHE A 181 SITE 2 AC2 10 ASN A 410 ALA A 414 ASN A 419 TRP A 422 SITE 3 AC2 10 THR A 423 TYR A 426 CRYST1 59.032 77.399 163.822 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016940 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012920 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006104 0.00000